Document Detail


Local matrix metalloproteinase 2 gene knockdown in balloon-injured rabbit carotid arteries using nonviral-small interfering RNA transfection.
MedLine Citation:
PMID:  19040207     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Small interfering RNA (siRNA) delivery is a promising approach for the treatment of cardiovascular diseases. Matrix metalloproteinase (MMP) 2 over-expression in the arterial wall has been implicated in restenosis after percutaneous coronary intervention, as well as in spontaneous atherosclerotic plaque rupture. We hypothesized that in vivo local delivery of siRNA targeted at MMP2 (MMP2-siRNA) in the balloon-injured carotid artery of hypercholesterolemic rabbits may lead to inhibition of MMP2 expression. METHODS: Two weeks after balloon injury, 5 micromol/l of Tamra-tagged MMP2-siRNA, scramble siRNA or saline was locally injected in the carotid artery and incubated for 1 h. RESULTS: Fluorescent microscopy studies showed the circumferential uptake of siRNA in the superficial layers of neointimal cells. MMP2 mRNA levels, measured by the real-time reverse transcriptase-polymerase chain reaction, was decreased by 79 +/- 25% in MMP2-siRNA- versus scramble siRNA-transfected arteries (p < 0.05). MMP2 activity, measured by gelatin zymography performed on the conditioned media of MMP2-siRNA versus scramble siRNA transfected arteries, decreased by 53 +/- 29%, 50 +/- 24% and 46 +/- 14% at 24, 48 and 72 h, respectively (p < 0.005 for all). No effect was observed on MMP9, pro-MMP9 and TIMP-2 levels. CONCLUSIONS: The results obtained in the present study suggest that significant inhibition of gene expression can be achieved with local delivery of siRNA in the arterial wall in vivo.
Authors:
Hanna Hlawaty; Aurélie San Juan; Marie-Paule Jacob; Roger Vranckx; Didier Letourneur; Laurent J Feldman
Related Documents :
8409037 - Sequential intravascular ultrasound characterization of the mechanisms of rotational at...
16620697 - Compensatory enlargement in transplant coronary artery disease: an intravascular ultras...
13679647 - Pathogenesis of the acute coronary syndromes and therapeutic implications.
441387 - Heparin-induced thromboembolism: angiographic features.
14697457 - Increased coronary arterial release of interleukin-1 receptor antagonist and soluble cd...
8316267 - A comparison of directional atherectomy with balloon angioplasty for lesions of the lef...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The journal of gene medicine     Volume:  11     ISSN:  1521-2254     ISO Abbreviation:  J Gene Med     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2009-01-05     Completed Date:  2009-02-05     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815764     Medline TA:  J Gene Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  92-9     Citation Subset:  IM    
Copyright Information:
(c) 2008 John Wiley & Sons, Ltd.
Affiliation:
INSERM U698, Bioingénierie Cardiovasculaire, CHU Bichat Université Paris 13, 46 rue Henri Huchard, 75877 Paris Cedex 18, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Balloon / adverse effects
Animals
Carotid Arteries / enzymology*,  pathology*
Carotid Artery Injuries / genetics,  therapy*
Disease Models, Animal
Immunohistochemistry
Male
Matrix Metalloproteinase 2 / antagonists & inhibitors*,  genetics,  metabolism
Matrix Metalloproteinase 9 / genetics,  metabolism
RNA Interference*
RNA, Messenger / metabolism
RNA, Small Interfering / administration & dosage*,  metabolism
Rabbits
Tissue Inhibitor of Metalloproteinase-2 / genetics,  metabolism
Transfection
Chemical
Reg. No./Substance:
0/RNA, Messenger; 0/RNA, Small Interfering; 127497-59-0/Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabili...
Next Document:  Asymmetric stem cell division and pathology: insights from Drosophila stem cell systems.